Research Medical
ILLUMINATE
Innovation in Personalized Cancer Treatment
MeMRI Technology
The ILLUMINATE project enhances theranostic treatments for metastatic prostate cancer using MeMRI technology, which visualizes tumor growth and treatment response. By combining diagnosis, therapy, and follow-up, theranostics offers personalized care.
Better Treatment Decisions
ILLUMINATE focuses on more effective use of lutetium-177 and its sustainable production. The project contributes to better treatment decisions, fewer side effects, and broader application of MeMRI in other cancer types.